About Four-jointed box protein 1
Four-jointed box protein 1 (FJX1) is a protein
from Homo sapiens identified by UniProt accession
Q86VR8, 437 residues long.
MolForge cross-references it against 0 known binders and
63 disease associations.
Target properties
| Protein name | Four-jointed box protein 1 |
| UniProt accession | Q86VR8 |
| Gene | FJX1 |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (63)
Diseases linked to this target (Open Targets).
- neoplasm · score 0.09
- cancer · score 0.09
- Testicular regression syndrome · score 0.05
- gonorrhea · score 0.04
- 46,XX ovotesticular disorder of sex development · score 0.04
- 46,XX gonadal dysgenesis · score 0.04
- 46,XY complete gonadal dysgenesis · score 0.04
- primary ovarian insufficiency · score 0.04
- caudal duplication · score 0.04
- testicular agenesis · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86VR8-F1 | alphafold | PREDICTED | 79.01 | — |
Amino-acid sequence (437 residues)
MGRRMRGAAA TAGLWLLALG SLLALWGGLL PPRTELPASR PPEDRLPRRP ARSGGPAPAP RFPLPPPLAW DARGGSLKTF RALLTLAAGA DGPPRQSRSE PRWHVSARQP RPEESAAVHG GVFWSRGLEE QVPPGFSEAQ AAAWLEAARG ARMVALERGG CGRSSNRLAR FADGTRACVR YGINPEQIQG EALSYYLARL LGLQRHVPPL ALARVEARGA QWAQVQEELR AAHWTEGSVV SLTRWLPNLT DVVVPAPWRS EDGRLRPLRD AGGELANLSQ AELVDLVQWT DLILFDYLTA NFDRLVSNLF SLQWDPRVMQ RATSNLHRGP GGALVFLDNE AGLVHGYRVA GMWDKYNEPL LQSVCVFRER TARRVLELHR GQDAAARLLR LYRRHEPRFP ELAALADPHA QLLQRRLDFL AKHILHCKAK YGRRSGT
Explore Four-jointed box protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets